Scholarlink

Purpose of Review <p>It is well established that South Africa has the highest prevalence of human immunodeficiency virus (HIV) worldwide. The increasing widespread availability of combination antiretroviral therapy (cART) has improved the life-expectancy of people living with HIV. cART has dramatically reduced morbidity, however many people living with HIV continue to experience central nervous system (CNS) complications including neuropsychiatric conditions such as depression, anxiety, and neurocognitive disorders.</p> Recent Findings <p>The pathological effects of HIV on the CNS have not been well elucidated. There are limited studies focusing on the prevalence, screening, and treatment strategies of HIV-associated neurocognitive disorder (HAND) in South Africa. The few studies included in this review indicate that the prevalence of HAND may be higher than estimated. In addition, only a limited number of cases have been reported. This may be due to a lack of registry, screening tools, expertise, and awareness.</p> Summary <p>This review aimed to provide an overview of HAND in South Africa including prevalence, screening, and current treatment strategies. Whether South Africa has the necessary and effective screening tools remains to be determined; however, HAND screening should be mandated for all HIV-infected individuals. cART remains the mainstay treatment of HAND, currently there are no alternative treatment strategies other than adjuvant therapies. In addition, it is yet to be established whether cART plays a role in the development of HAND.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

An Overview of HIV-associated Neurocognitive Disorder in South Africa

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年1月29日

查看全文
  • Brian Thabile Flepisi,
  • Marissa Balmith

摘要

Purpose of Review

It is well established that South Africa has the highest prevalence of human immunodeficiency virus (HIV) worldwide. The increasing widespread availability of combination antiretroviral therapy (cART) has improved the life-expectancy of people living with HIV. cART has dramatically reduced morbidity, however many people living with HIV continue to experience central nervous system (CNS) complications including neuropsychiatric conditions such as depression, anxiety, and neurocognitive disorders.

Recent Findings

The pathological effects of HIV on the CNS have not been well elucidated. There are limited studies focusing on the prevalence, screening, and treatment strategies of HIV-associated neurocognitive disorder (HAND) in South Africa. The few studies included in this review indicate that the prevalence of HAND may be higher than estimated. In addition, only a limited number of cases have been reported. This may be due to a lack of registry, screening tools, expertise, and awareness.

Summary

This review aimed to provide an overview of HAND in South Africa including prevalence, screening, and current treatment strategies. Whether South Africa has the necessary and effective screening tools remains to be determined; however, HAND screening should be mandated for all HIV-infected individuals. cART remains the mainstay treatment of HAND, currently there are no alternative treatment strategies other than adjuvant therapies. In addition, it is yet to be established whether cART plays a role in the development of HAND.